Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q26853239)
Watch
English
New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
title
New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel
(English)
1 reference
stated in
PubMed
author
Ursula Schmidt-Erfurth
1 reference
stated in
ORCID Public Data File 2021
author name string
F Bandello
series ordinal
1
1 reference
stated in
Crossref
J Cunha-Vaz
series ordinal
2
1 reference
stated in
Crossref
N V Chong
series ordinal
3
1 reference
stated in
Crossref
G E Lang
series ordinal
4
1 reference
stated in
Crossref
P Massin
series ordinal
5
1 reference
stated in
Crossref
P Mitchell
series ordinal
6
1 reference
stated in
Crossref
M Porta
series ordinal
7
1 reference
stated in
Crossref
C Prünte
series ordinal
8
1 reference
stated in
Crossref
R Schlingemann
series ordinal
9
1 reference
stated in
Crossref
U Schmidt-Erfurth
series ordinal
10
1 reference
stated in
Crossref
language of work or name
English
1 reference
stated in
PubMed
publication date
April 2012
1 reference
stated in
PubMed
published in
Eye
1 reference
stated in
PubMed
volume
26
1 reference
stated in
PubMed
issue
4
1 reference
stated in
PubMed
page(s)
485-93
1 reference
stated in
PubMed
cites work
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
7 April 2017
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
7 April 2017
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
7 April 2017
The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Burden of illness of diabetic macular edema: literature review
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Diabetic macular edema: pathogenesis and treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Diabetic macular edema associated with glitazone use.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Risk factors for diffuse and focal macular edema
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Macular edema. A complication of diabetic retinopathy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325561
retrieved
28 September 2017
Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FEYE.2011.337
retrieved
21 January 2018
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FEYE.2011.337
retrieved
21 January 2018
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FEYE.2011.337
retrieved
21 January 2018
Spontaneous resolution of diabetic macular oedema after discontinuation of thiazolidenediones
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FEYE.2011.337
retrieved
21 January 2018
Diabetes and cardiovascular risk factors: the Framingham study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22241014
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22241014
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22241014
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Effect of multifactorial intervention on diabetic macular edema
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22241014
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Diabetic retinopathy
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22241014
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Photocoagulation for Diabetic Macular Edema
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FEYE.2011.337
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/EYE.2011.337
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4587180
Dimensions Publication ID
1037444576
0 references
OpenCitations bibliographic resource ID
4587180
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4587180
PMC publication ID
3325561
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4587180
PubMed publication ID
22241014
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4587180
ResearchGate publication ID
221743753
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
